A Breakthrough Treatment for Dry Age-Related Macular Degeneration (AMD)

No injections. No dilation. Just light.

At Charles Retina Institute, we are proud to offer the Valeda® Light Delivery System—the first approved treatment designed to improve visual function in patients with dry AMD.

Using photobiomodulation (PBM) therapy, Valeda delivers safe, non-invasive light-based treatments that:

• Support retinal health by reducing oxidative stress and inflammation
• Improve contrast sensitivity, reading ability, and overall visual function
• Slow the progression of dry AMD in eligible patients

The treatment is quick, comfortable, and performed right here in our office. Sessions last only minutes and are completed over a few weeks—helping you protect and preserve your vision with ease.

As leaders in advanced retinal care, Charles Retina Institute is committed to bringing our patients the latest proven innovations. Offering Valeda® is part of our mission to serve as a Center of Excellence in macular degeneration care.

If you or a loved one has been diagnosed with dry AMD, schedule a consultation today to see if Valeda® is right for you.